Surgery
Volume 147, Issue 3 , Pages 415-423 , March 2010

Timing-dependent protection of hypertonic saline solution administration in experimental liver ischemia/reperfusion injury

,Accepted 5 October 2009.

References 

  1. Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of the ischemic liver by donor pre-treatment before transplantation. Am J Surg. 1975;129:513–517
  2. Moussa ME, Sarraf CE, Uemoto S, Sawada H, Habib NA. Effect of total hepatic vascular exclusion during liver resection on hepatic ultrastructure. Liver Transpl Surg. 1996;2:461–467
  3. Gurfinkel V, Poggetti RS, Fontes B, da Costa Ferreira Novo F, Birolini D. Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. J Trauma. 2003;54:1137–1145
  4. Platz KP, Mueller AR, Schäfer C, Jahns S, Guckelberger O, Neuhaus P. Influence of warm ischemia time on initial graft function in human liver transplantation. Transplant Proc. 1997;29:3458–3459
  5. Pegg DE. Organ preservation. Surg Clin North Am. 1986;66:617–632
  6. Nauta RJ, Tsimoyiannis E, Uribe M, Walsh DB, Miller D, Butterfield A. The role of calcium ions and calcium channel entry blockers in experimental ischemia/reperfusion induced liver injury. Ann Surg. 1991;213:137–142
  7. Anderson CD, Pierce J, Nicoud I, Belous A, Knox CD, Chari RS. Modulation of mitochondrial calcium management attenuates hepatic warm ischemia/reperfusion injury. Liver Transpl. 2005;11:663–668
  8. Miranda LE, Viaro F, Ceneviva R, Evora PR. [Is the mitochondrial respiratory activity a good parameter for hepatic ischemia and reperfusion injury?]. Arq Gastroenterol. 2005;42:89–94
  9. Nicoud IB, Knox CD, Jones CM, Anderson CD, Pierce JM, Belous AE, et al. 2-APB protects against liver ischemia/reperfusion injury by reducing cellular and mitochondrial calcium uptake. Am J Physiol Gastrointest Liver Physiol. 2007;293:623–630
  10. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ. Role of neutrophils during the first 24 hours after liver ischemia and reperfusion injury. Transplant Proc. 1994;26:3695–3700
  11. Lichtman SN, Lemasters JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis. 1999;19:171–187
  12. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169–173
  13. Abdo EE, Cunha JEM, Deluca P, Coelho AMM, Bacchella T, Machado MCC. Protective effect of N-2 mercaptopropionylglycine on rats and dogs liver during ischemia/reperfusion process. Arq Gastroenterol. 2003;40:177–180
  14. Coimbra R, Hoyt DB, Junger WG, Angle N, Wolf P, Loomis W, et al. Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma. 1997;42:602–606
  15. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161:6288–6296
  16. Patel S, Pachter HL, Yee H, Schwartz JD, Marcus SG, Shamamian P. Topical hepatic hypothermia attenuates pulmonary injury after hepatic ischemia and reperfusion. J Am Coll Surg. 2000;191:650–656
  17. de Felippe J, Timoner J, Velasco IT, Lopes OU, Rocha-e-Silva M. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections. Lancet. 1980;2:1002–1004
  18. Velasco IT, Pontieri V, Rocha e Silva M, Lopes OU. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol. 1980;239:664–673
  19. Rocha-e-Silva M, Poli de Figueiredo LF. Small volume hypertonic resuscitation of circulatory shock. Clinics. 2005;60:159–172
  20. Worthley LI, Cooper DJ, Jones N. Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases. J Neurosurg. 1988;68:478–481
  21. Mattox KL, Maningas PA, Moore EE, Mateer JR, Marx JA, Aprahamian C, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg. 1991;213:482–491
  22. Oreopoulos GD, Wu H, Szaszi K, Fan J, Marshall JC, Khadaroo RG, et al. Hypertonic preconditioning prevents hepatocellular injury following ischemia/reperfusion in mice: a role for interleukin 10. Hepatology. 2004;40:211–220
  23. Institute of Laboratory Animal Resources . Commission on Life Sciences, National Research Council. Guide for the care and use of laboratory animals. 7th ed.. Washington (DC): National Academy Press; 1996;
  24. Yoshizumi T, Yanaga K, Soejima Y, Maeda T, Uchiyama H, Sugimachi K. Amelioration of liver injury by ischaemic preconditioning. Br J Surg. 1998;85:1636–1640
  25. Canedo LF, Machado MA, Coelho AM, Sampietre SN, Bacchella T, Machado MC. [Protective effects of an inhibitor of glycoprotein IIb/IIIa in the hepatic and pulmonary disturbances secondary to ischemia and reperfusion injury of rat's liver.]. Arq Gastroenterol. 2007;44:276–281
  26. Madrahimov N, Dirsch O, Broelsch C, Dahmen U. Marginal hepatectomy in the rat: from anatomy to surgery. Ann Surg. 2006;244:89–98
  27. Coelho AM, Machado MC, Sampietre SN, Leite KR, Oliveira VL, Pinotti HW. Hepatic damage during acute pancreatitis in the rat. Braz J Med Biol Res. 1997;30:947–953
  28. Estabrook R, Pullman M. Oxidation and phosphorylation. In:  Estabrook RW,  Pullman ME editor. Methods in enzymology. New York: Academic Press; 1967;
  29. Chance B, Williams GR. A simple and rapid assay of oxidative phosphorylation. Nature. 1955;175:1120–1121
  30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
  31. Jancar S, De Giaccobi G, Mariano M, Mencia-Huerta JM, Sirois P, Braquet P. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins. 1988;35:757–770
  32. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol. 1985;59:1978–1985
  33. Warren JS, Yabroff KR, Mandel DM, Johnson KJ, Ward PA. Role of O2- in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Radic Biol Med. 1990;8:163–172
  34. Quireze C, Montero EF, Leitão RM, Juliano Y, Fagundes DJ, Poli-de-Figueiredo LF. Ischemic preconditioning prevents apoptotic cell death and necrosis in early and intermediate phases of liver ischemia/reperfusion injury in rats. J Invest Surg. 2006;19:229–236
  35. Chiara O, Pelosi P, Brazzi L, Bottino N, Taccone P, Cimbanassi S, et al. Resuscitation from hemorrhagic shock: experimental model comparing normal saline, dextran, and hypertonic saline solutions. Crit Care Med. 2003;31:1915–1922
  36. Shi HP, Deitch EA, Da Xu Z, Lu Q, Hauser CJ. Hypertonic saline improves intestinal mucosa barrier function and lung injury after trauma-hemorrhagic shock. Shock. 2002;17:496–501
  37. Norenberg MD, Papendick RE. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann Neurol. 1984;15:544–547
  38. Goh KP. Management of hyponatremia. Am Fam Physician. 2004;69:2387–2394
  39. Pascual JL, Khwaja KA, Chaudhury P, Christou NV. Hypertonic saline and the microcirculation. J Trauma. 2003;54:S133–S140
  40. Nolte D, Bayer M, Lehr HA, Becker M, Krombach F, Kreimeier U, et al. Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran. Am J Physiol. 1992;263:H1411–H1416
  41. Oreopoulos GD, Hamilton J, Rizoli SB, Fan J, Lu Z, Li YH, et al. In vivo and in vitro modulation of intercellular adhesion molecule (ICAM)- 1 expression by hypertonicity. Shock. 2000;14:409–414
  42. Townsend MC, Yokum MD, Fry DE. Hepatic microsomal adenosine triphosphatase and mitochondrial function. Response to cold and warm ischemia. Arch Surg. 1987;122:813–816
  43. Machado MC, Coelho AM, Pontieri V, Sampietre SN, Molan NA, Soriano F, et al. Local and systemic effects of hypertonic solution (NaCl 7.5%) in experimental acute pancreatitis. Pancreas. 2006;32:80–86
  44. Santen S, Schramm R, Menger MD, Wang Y, Jeppsson B, Thorlacius H. P-selectin glycoprotein ligand-1 regulates chemokine-dependent leukocyte recruitment in colonic ischemia-reperfusion. Inflamm Res. 2007;56:452–458
  45. Ke QH, Zheng SS, Liang TB, Xie HY, Xia WL. [Effects of hypertonic saline on expression of heme oxygenase enzyme-1 in hepatic ischemia/reperfusion injury rats]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006;18:5–8
  46. Mitsuoka H, Unno N, Sakurai T, Kaneko H, Suzuki S, Konno H, et al. Pathophysiological role of endothelins in pulmonary microcirculatory disorders due to intestinal ischemia and reperfusion. J Surg Res. 1999;87:143–151
  47. Angle N, Hoyt DB, Cabello-Passini R, Herdon-Remelius C, Loomis W, Junger WG. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma. 1998;45:7–12
  48. Oreopoulos GD, Bradwell S, Lu Z, Fan J, Khadaroo R, Marshall JC, et al. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages. Surgery. 2001;130:157–165

 This work was supported by grant 05/04226-7 from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

PII: S0039-6060(09)00628-X

doi: 10.1016/j.surg.2009.10.018

Surgery
Volume 147, Issue 3 , Pages 415-423 , March 2010